RAYNER WEBINAR | Returning to work with premium IOLs plus RayPRO as a contactless telehealth solution for collecting patient outcomes data

Posted on 4/06/2020

Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy

Read more

WEBINAR | Returning to work with premium IOLs

Posted on 22/05/2020

Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported Outcomes (PROs). The speakers will also talk about returning to clinic after COVID-19. The webinar will last 1 hour (includes 15-minute Question & Answer session).

Read more

Rayner re-opens commercial office Monday 18th May

Posted on 18/05/2020

In order to serve hospitals, surgeons and patients around the world in need of cataract surgery and ophthalmic treatment, Rayner has today opened its commercial office. This means that our customer service, technical support and logistics teams are available to serve our customers as normal. Our factory never stopped producing our award-winning intraocular lenses meaning

Read more

Rayner Takes Bold Measures to Prepare for NHS Support Once Cataract Surgery Resumes

Posted on 14/05/2020

Worthing (UK) – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and last month revealed as a winner of the 2020 Queen’s Awards for Enterprise (Innovation) for its RayOne IOL injector system, announced today that it substantially increased IOL production levels between January and April, despite NHS elective surgery being postponed

Read more

Industry Announcement: Winner of Queen’s Award for Enterprise 2020 (Innovation). Rayner RayOne Fully Preloaded IOL Injection System

Posted on 21/04/2020

Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in

Read more

General Announcement: Winner of Queen’s Award for Enterprise 2020 (Innovation). Rayner RayOne Fully Preloaded IOL Injection System for Treating Cataracts

Posted on 21/04/2020

Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in

Read more

COVID-19 Rayner Announcement

Posted on 20/03/2020

Dear All, I want to reassure you in these uncertain times. Rayner is very fortunate to operate globally and in an industry which is critical. Despite the worsening situation in Europe and the Americas we are thankfully seeing improvements in Asia. Several large markets are operating relatively unaffected. Despite the turmoil that we see on

Read more

Rayner launching RayOne Trifocal Toric at ESCRS to complete its trifocal IOL family

Posted on 11/09/2019

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Read more

Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia.

Posted on 1/09/2019

Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia. Following a four-year R&D collaboration on a novel hydrophobic IOL material, Rayner has acquired a substantial stake in Reper, a leading material science and medical device company based in Russia. The new proprietary non-glistening material is the basis for RayOne

Read more

US surgeons to access the smallest fully preloaded IOL incision. RayOne Aspheric receives FDA clearance.

Posted on 11/12/2018

Rayner set to launch 600C monofocal aspheric IOL at ASCRS

Rayner has announced the launch of the 600C Aspheric IOL. The 600C Aspheric IOL will be unveiled at the upcoming 2018 ASCRS conference in Washington, DC, 13-17 A...

Read more